Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE:DBD)
Vietnam
· Delayed Price · Currency is VND 49,750
0.00 (0.00%)
At close: Apr 28, 2026
HOSE:DBD Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,865,380 | 1,727,548 | 1,651,770 | 1,554,821 | 1,558,504 | Upgrade
|
| Revenue Growth (YoY) | 7.98% | 4.59% | 6.24% | -0.24% | 23.99% | Upgrade
|
| Cost of Revenue | 981,001 | 894,975 | 853,250 | 787,170 | 935,939 | Upgrade
|
| Gross Profit | 884,379 | 832,573 | 798,520 | 767,652 | 622,566 | Upgrade
|
| Selling, General & Admin | 558,103 | 526,981 | 501,538 | 494,312 | 405,437 | Upgrade
|
| Operating Expenses | 558,103 | 526,981 | 501,538 | 494,312 | 405,437 | Upgrade
|
| Operating Income | 326,276 | 305,592 | 296,982 | 273,339 | 217,129 | Upgrade
|
| Interest Expense | -3,847 | -4,058 | -6,998 | -1,916 | -1,325 | Upgrade
|
| Interest & Investment Income | 20,036 | 11,605 | 11,635 | 8,733 | 5,137 | Upgrade
|
| Earnings From Equity Investments | 12,280 | 27,063 | 28,704 | 24,786 | 16,083 | Upgrade
|
| Currency Exchange Gain (Loss) | 2,644 | -947.49 | -482.96 | 354.16 | 733.11 | Upgrade
|
| Other Non Operating Income (Expenses) | -11,308 | -12,119 | -9,753 | -6,739 | -5,310 | Upgrade
|
| EBT Excluding Unusual Items | 346,082 | 327,136 | 320,086 | 298,558 | 232,448 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -2,000 | - | - | - | Upgrade
|
| Pretax Income | 346,082 | 325,136 | 320,086 | 298,558 | 232,448 | Upgrade
|
| Income Tax Expense | 54,142 | 49,954 | 51,031 | 55,003 | 43,324 | Upgrade
|
| Net Income | 291,940 | 275,182 | 269,055 | 243,555 | 189,124 | Upgrade
|
| Preferred Dividends & Other Adjustments | 40,918 | 38,525 | 37,668 | 34,098 | 26,477 | Upgrade
|
| Net Income to Common | 251,022 | 236,656 | 231,387 | 209,457 | 162,646 | Upgrade
|
| Net Income Growth | 6.09% | 2.28% | 10.47% | 28.78% | 19.80% | Upgrade
|
| Shares Outstanding (Basic) | 94 | 94 | 94 | 94 | 94 | Upgrade
|
| Shares Outstanding (Diluted) | 94 | 94 | 94 | 94 | 94 | Upgrade
|
| Shares Change (YoY) | 0.34% | - | -0.00% | - | -0.07% | Upgrade
|
| EPS (Basic) | 2673.96 | 2529.63 | 2473.31 | 2238.88 | 1738.52 | Upgrade
|
| EPS (Diluted) | 2673.96 | 2529.63 | 2473.00 | 2238.88 | 1738.52 | Upgrade
|
| EPS Growth | 5.71% | 2.29% | 10.46% | 28.78% | 17.16% | Upgrade
|
| Free Cash Flow | 206,614 | 115,985 | 148,663 | 82,184 | 62,932 | Upgrade
|
| Free Cash Flow Per Share | 2200.91 | 1239.77 | 1589.06 | 878.47 | 672.68 | Upgrade
|
| Dividend Per Share | - | 2000.000 | - | 1600.000 | - | Upgrade
|
| Gross Margin | 47.41% | 48.19% | 48.34% | 49.37% | 39.95% | Upgrade
|
| Operating Margin | 17.49% | 17.69% | 17.98% | 17.58% | 13.93% | Upgrade
|
| Profit Margin | 13.46% | 13.70% | 14.01% | 13.47% | 10.44% | Upgrade
|
| Free Cash Flow Margin | 11.08% | 6.71% | 9.00% | 5.29% | 4.04% | Upgrade
|
| EBITDA | 375,841 | 353,705 | 342,951 | 315,005 | 255,818 | Upgrade
|
| EBITDA Margin | 20.15% | 20.47% | 20.76% | 20.26% | 16.41% | Upgrade
|
| D&A For EBITDA | 49,565 | 48,112 | 45,970 | 41,665 | 38,689 | Upgrade
|
| EBIT | 326,276 | 305,592 | 296,982 | 273,339 | 217,129 | Upgrade
|
| EBIT Margin | 17.49% | 17.69% | 17.98% | 17.58% | 13.93% | Upgrade
|
| Effective Tax Rate | 15.64% | 15.36% | 15.94% | 18.42% | 18.64% | Upgrade
|
| Revenue as Reported | 1,865,380 | 1,727,548 | 1,651,770 | 1,554,821 | 1,558,504 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.